Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy

International Journal of Cardiology

Volumn 118, Issue 2, 2007, Pages 206-214

  Parthenakis, Frangiskos I ^a   Patrianakos, Alexandros P ^a   Skalidis, Emmanuel I ^a   Diakakis, George F ^a   Zacharis, Evangelos A ^a   Chlouverakis, Gregory ^a   Karalis, Ioannis K ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Atrial fibrillation; Natriuretic peptide; Non ischemic dilated cardiomyopathy; Pro inflammatory cytokines

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; NEUROHORMONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIAC PATIENT; CONGESTIVE CARDIOMYOPATHY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; MYOCARDITIS; OXYGEN CONSUMPTION; POPULATION RESEARCH; PRIORITY JOURNAL; SINUS RHYTHM;

ATRIAL FIBRILLATION; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; CYTOKINES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDES; NEUROTRANSMITTER AGENTS; OXYGEN CONSUMPTION; VENTRICULAR FUNCTION, LEFT;

EID: 34247125688     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.090     Document Type: Article

References (43)

1. Crijns H.J., Tjeerdsma G., de Kam P.J., et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21 15 (2000) 1207-1208
2. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., and Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32 (1998) 695-703
3. The CONSENSUS Clinical Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the COoperative North Scandinavian ENalapril SUrvival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
4. Deedwania P.C., Singh B.N., Ellenbogen K., Fisher S., Fletcher R., and Singh S.N. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation 98 (1998) 2574-2579
5. Stevenson W.G., and Stevenson L.W. Atrial fibrillation in heart failure. N Engl J Med 341 (1999) 910-911
6. Chugh S.S., Blackshear J.L., Shen W.K., Hammill S.C., and Gersh B.J. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37 (2001) 371-378
7. Scheinman M.M. Atrial fibrillation and congestive heart failure. The intersection of two common diseases. Circulation 98 (1998) 941-942
8. Maisel W.H., and Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. J Am Coll Cardiol 91 (2003) 2D-8D [suppl]
9. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
10. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20 (1999) 683-693
11. Gosselink A.T., Bijlsma E.B., Landsman M.L., Crijns H.J., and Lie K.I. Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation: a 2-year follow-up. Eur Heart J 15 (1994) 1368-1372
12. Ueshima K., Myers J., Morris C.K., Atwood J.E., Kawaguchi T., and Froelicher V.F. The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am Heart J 126 (1993) 1021-1024
13. Pardaens K., Van Cleemput J., Vanhaecke J., and Fagard R.H. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart 78 (1997) 564-568
14. Carson P.E., Johnson G.R., Dunkman W.B., Fletcher R.D., Farrell L., and Cohn J.N. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT studies. Circulation 87 Suppl VI (1993) 102-110
15. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on Standards, Subcommittee on Quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 5 (1989) 358-367
16. Utsunomiya T., Doshi R., Patel D., et al. Calculation of volume flow rate by the proximal isovelocity surface area method: simplified approach using color Doppler zero baseline shift. J Am Coll Cardiol 22 1 (1993) 277-282
17. Xie G.Y., Berk M.R., Smith M.D., Gurley J.C., and De Maria A.N. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 24 (1994) 132-139
18. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (1988), Lawerence Earlbaum Associates, Hillsdale, NJ
19. Kadish A., Dyer A., Daubert J.P., et al., for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
20. Zugck C., Kruger C., Durr S., et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?. Eur Heart J 21 (2000) 540-549
21. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
22. Aukrust P., Ueland T., Lien E., et al. Cytokine network in congestive heart failure secondary to ischemic of idiopathic dilated cardiomyopathy. J Am Coll Cardiol 83 (1999) 376-382
23. Aukrust P., Yndestad A., Damas J.K., and Gullestad L. Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin. Autoimmun Rev 3 3 (2004) 221-227
24. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. The Framingham Heart Study. Circulation 107 (2003) 2920-2925
25. Middlekauff H.R., Stevenson W.G., and Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 84 (1991) 40-48
26. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery post-surgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
27. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
28. Chung M., Martin D., Sprecher D., et al. C-reactive protein in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
29. Dernelis J., and Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 56 (2001) 375-380
30. Temporelli P.L., Scapellato F., Corra U., Eleuteri E., Imparato A., and Giannuzzi P. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol 83 (1999) 724-727
31. Traversia E., Cobellia F., and Pozzoli M. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure even when atrial fibrillation is present. Eur J Heart Fail 3 (2001) 173-181
32. Kapadia S.R., Yakoob K., Nader S., Thomas J.D., Mann D.L., and Griffin B.P. Elevated circulating levels of serum tumor necrosis factor-alpha in pts with hemodynamically significant pressure and volume overload. JACC 36 1 (2000) 208-212
33. Silvet H., Young-Xu Y., Walleigh D., and Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. J Am Coll Cardiol 92 9 (2003) 1124-1127
34. Rossi A., Enriquez-Sarano M., Burnett Jr. J.C., Lerman A., Abel M.D., and Seward J.B. Natriuretic peptide levels in atrial fibrillation. A prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35 (2000) 1256-1262
35. Tuinenburg A.E., Van Veldhuisen D.J., Boomsma F., Van Den Berg M.P., De Kam P.J., and Crijns H.J. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. J Am Coll Cardiol 81 15 (1988) 1207-1210
36. Latini R., et al., For the Val-HeFT Investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25 (2004) 292-299
37. Patrianakos A.P., Parthenakis F.I., Papadimitriou E.A., et al. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy. Eur J Heart Fail 6 (2004) 735-743
38. Kruger S., Graf J., Kunz D., Stickel T., Hanrath P., and Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 40 4 (2002) 718-722
39. Tsang T.S., Gersh B.J., DPhil, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40 9 (Nov 6 2002) 1636-1644
40. Volterrani M., Clark A.L., Ludman P.F., et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J 15 (1994) 801-809
41. Franciosa J.A., Baker B.J., and Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 110 (1985) 807-813
42. van den Berg P.M., Tuinenburg E.A., van Veldhuisen J.D., de Kam P.J., and Crijns H. Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure. Int J Cardiol 63 (1998) 63-70
43. Van Den Berg M.P., Crijns H.J., Van Veldhuisen D.J., Van Gelder I.C., De Kam P.J., and Lie K.I. Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation; role of duration of atrial fibrillation. Am Heart J 135 (1998) 242-244